Statistics for Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC

Total visits

views
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC 2

Total visits per month

views
September 2024 0
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0

File Visits

views
java.util.UUID:2c39efa2-aa93-41a2-b4e1-aaff18d39461 25
java.util.UUID:2ae12be5-2a3a-46e8-b3a4-938d91a1cf59 10
java.util.UUID:ada99203-60a1-49cd-b5e9-7c140a5a0ea5 10
Evans2022Augmenting-CCBY.pdf 5

Top country views

views
United States 2

Top city views

views
Franklin 2